Skip to Main Content

Author Details

Katie M Campbell
McDonnell Genome Institute, Washington University School of Medicine
2014
38
19
PMIDPaper TitleJournal TitlePublished Year
36251745Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma.Blood Adv2023
36949070Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer.Nat Commun2023
36373660CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase.Nucleic Acids Res2023
36356599Non-viral precision T cell receptor replacement for personalized cell therapy.Nature2023
35264439Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy.J Immunother Cancer2022
35624339A community approach to the cancer-variant-interpretation bottleneck.Nat Cancer2022
36588582Remodeling of the tumor microenvironment through PAK4 inhibition sensitizes tumors to immune checkpoint blockade.Cancer Res Commun2022
35058328Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders.J Immunother Cancer2022
33355178Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited.Cancer Discov2021
35611186<i>In silico</i> epitope prediction analyses highlight the potential for distracting antigen immunodominance with allogeneic cancer vaccines.Cancer Res Commun2021
33547198Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas.Clin Cancer Res2021
34778796How to Provide the Needed Protection from COVID-19 to Patients with Hematologic Malignancies.Blood Cancer Discov2021
34506690Exploring the Genomic Landscape of Cancer Patient Cohorts with GenVisR.Curr Protoc2021
34385448Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma.Nat Commun2021
34326162Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma.Cancer Discov2021
33407605Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge" (December 4th-5th, 2019, Naples, Italy).J Transl Med2021
33306984Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma.Cancer Cell2021
33397681Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II Trial.Clin Cancer Res2021
32511325Prioritization of SARS-CoV-2 epitopes using a pan-HLA and global population inference approach.bioRxiv2020
33288749PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma.Nat Commun2020
33055240Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma.Sci Transl Med2020
32665297Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial.Clin Cancer Res2020
32699033Epigenetic Suppression of Transgenic T-cell Receptor Expression via Gamma-Retroviral Vector Methylation in Adoptive Cell Transfer Therapy.Cancer Discov2020
32467343Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade.Cancer Discov2020
30287923Standard operating procedure for somatic variant refinement of sequencing data with paired tumor and normal samples.Genet Med2019
31462330Best practices for bioinformatic characterization of neoantigens for clinical utility.Genome Med2019
31390566A Spontaneous Aggressive ERα+ Mammary Tumor Model Is Driven by Kras Activation.Cell Rep2019
31618044Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion Probes.JCO Clin Cancer Inform2019
30397337A deep learning approach to automate refinement of somatic variant calling from cancer sequencing data.Nat Genet2018
30134176Oral Cavity Squamous Cell Carcinoma Xenografts Retain Complex Genotypes and Intertumor Molecular Heterogeneity.Cell Rep2018
30181556The prognostic effects of somatic mutations in ER-positive breast cancer.Nat Commun2018
30429476Author Correction: The prognostic effects of somatic mutations in ER-positive breast cancer.Nat Commun2018
28434888Melorheostosis: Exome sequencing of an associated dermatosis implicates postzygotic mosaicism of mutated KRAS.Bone2017
28138153CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer.Nat Genet2017
27181063Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia.Exp Hematol2016
26531824DGIdb 2.0: mining clinically relevant drug-gene interactions.Nucleic Acids Res2016
27288499GenVisR: Genomic Visualizations in R.Bioinformatics2016
24607507RNAi screen in Drosophila larvae identifies histone deacetylase 3 as a positive regulator of the hsp70 heat shock gene expression during heat shock.Biochim Biophys Acta2014
  • 1 - 38 of 38

Recommended Authors

National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Career Start Year 2016
Number of shared co-authors 5
Washington University in St Louis
Career Start Year 2015
Number of shared co-authors 17
The University of Texas MD Anderson Cancer Center
Career Start Year 2014
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 0
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 13
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 4
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year 2008
Number of shared co-authors 0
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 2
University of California San Diego
Career Start Year 2008
Number of shared co-authors 3
St Vincent's Hospital Melbourne
Career Start Year 2006
Number of shared co-authors 2
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 2006
Number of shared co-authors 4
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 2
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 2
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 17
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 5
University of California
Career Start Year 2003
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 22
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 6
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 21
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Career Start Year 2001
Number of shared co-authors 2
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 3
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 27
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 13
Francis Crick Institute
Career Start Year 1997
Number of shared co-authors 9
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 52
Cleveland Clinic.
Career Start Year 1994
Number of shared co-authors 8
Broad Institute of Harvard and MIT
Career Start Year 1991
Number of shared co-authors 12

Collaborators

Washington University
Co-authored papers 23
Washington University
Co-authored papers 22
Washington University in St. Louis School of Medicine
Co-authored papers 20
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 13
University of California Los Angeles (university of california los angeles)
Co-authored papers 13
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 12
Washington University School of Medicine
Co-authored papers 11
The Ohio State University
Co-authored papers 10
McDonnell Genome Institute, Washington University in St Louis School of Medicine
Co-authored papers 9
Brigham and Women's Hospital
Co-authored papers 8
Iowa State University, Mayo Clinic, Nationwide Children's Hospital, The Ohio State University College of Medicine, University of Iowa, Washington University in Saint Louis
Co-authored papers 8
Washington University
Co-authored papers 8
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 5
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 5
The Ohio State University
Co-authored papers 5
Washington University
Co-authored papers 5
Stanford Cancer Institute, Stanford School of Medicine
Co-authored papers 5
McDonnell Genome Institute, Washington University in St Louis School of Medicine
Co-authored papers 5
German Cancer Consortium and German Cancer Research Center
Co-authored papers 4
University of Nevada
Co-authored papers 4
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 4
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 4
Ontario Institute for Cancer Research
Co-authored papers 4
Washington University
Co-authored papers 4
McDonnell Genome Institute, Washington University in St. Louis School of Medicine
Co-authored papers 3
McDonnell Genome Institute, Washington University in St Louis School of Medicine
Co-authored papers 3
Washington University School of Medicine
Co-authored papers 3
Harvard Medical School, Brigham and Women's Hospital
Co-authored papers 3
Washington University School of Medicine in St. Louis
Co-authored papers 3
McDonnell Genome Institute, Washington University in St Louis School of Medicine
Co-authored papers 3